Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Diffusion MRI-based cortical complexity alterations associated with executive function in multiple sclerosis.
Is there an increased risk of hip fracture in multiple sclerosis? Analysis of the Nationwide Inpatient Sample.
The human oligodendrocyte proteome.
Status epilepticus associated with dalfampridine in a patient with multiple sclerosis.
Central canal ependymal cells proliferate extensively in response to traumatic spinal cord injury but not demyelinating lesions.
Retrograde trans-synaptic degeneration in MS: A missing link?
Role of myelin sheath energy metabolism in neurodegenerative diseases.
Induction of heat shock protein 70 (Hsp70) prevents neuregulin-induced demyelination by enhancing the proteasomal clearance of c-Jun.
Mesenchymal stem cells inhibit lipopolysaccharide-induced inflammatory responses of BV2 microglial cells through TSG-6.
Dynamic molecular monitoring of retina inflammation by in vivo Raman spectroscopy coupled with multivariate analysis.
Oral versus intravenous steroids for treatment of relapses in multiple sclerosis.
Adrenergic regulation of innate immunity: a review.
Cognition, cognitive dysfunction, and cognitive rehabilitation in multiple sclerosis.
A Systematic Review of Pharmacological Pain Management in Multiple Sclerosis.
Ice Pick Headache.
Subcutaneous Transplantation of Neural Precursor Cells in Experimental Autoimmune Encephalomyelitis Reduces Chemotactic Signals in the Central Nervous System.
The Different Clinical Effects of Anti-BLyS, Anti-APRIL and Anti-CD20 Antibodies Point at a Critical Pathogenic Role of γ-Herpesvirus Infected B Cells in the Marmoset EAE Model.
Presence and significant determinants of cognitive impairment in a large sample of patients with multiple sclerosis.
Self-reports of executive functioning in multiple sclerosis: to trust or not to trust.
Anti-MOG antibodies are frequently associated with steroid-sensitive recurrent optic neuritis.
Natalizumab (TYSABRI) and multiple sclerosis. With longer follow-up: even more toxic than suspected.
Inadequacy of Clinical Trial Designs and Data to Control for the Confounding Impact of Race/Ethnicity in Response to Treatment in Multiple Sclerosis.
The efficacy and safety of daclizumab and its potential role in the treatment of multiple sclerosis.
Assessment of upper limb motor function in patients with multiple sclerosis using the Virtual Peg Insertion Test: A pilot study.
Global N-acetylaspartate concentration in benign and non-benign multiple sclerosis patients of long disease duration.

Pages